Structure and functional dynamics of virus-host protein interactions
病毒-宿主蛋白相互作用的结构和功能动力学
基本信息
- 批准号:10000945
- 负责人:
- 金额:$ 31.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-20 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:AffinityAntiviral AgentsBindingBinding SitesBiological AssayBiophysicsBirdsCell NucleusCellsCompetitive BindingComplexDataDevelopmentDiseaseEpidemicFutureGoalsHealthHumanImmune responseIn VitroInfectionInfluenza A virusIntegration Host FactorsKineticsKnowledgeMediatingMissionMolecularMolecular ConformationN-terminalNMR SpectroscopyNonstructural ProteinPathogenicityPhosphotransferasesPlayProcessProlineProteinsPublic HealthRecording of previous eventsResearchResolutionRoentgen RaysRoleSignal PathwaySignaling ProteinSiteSpanish fluStructural ModelsStructureTestingUnited States National Institutes of HealthViralVirulenceVirulence FactorsVirusVirus DiseasesVirus ReplicationZoonosesantiviral immunitybaseexperimental studyflexibilityinfluenzavirusinhibitor/antagonistmolecular dynamicspandemic diseasepandemic influenzapreventprogramsprotein protein interactionproto-oncogene protein c-crkseasonal influenzaswine influenzatargeted agenttherapeutic developmenttherapeutic target
项目摘要
The 1918 influenza A virus (IAV), also known as the Spanish flu, caused the worst influenza pandemic in human
history. Nonstructural protein 1 (NS1) is a multifunctional virulence factor associated with the suppression of anti-
viral immune responses and thereby has been identified as one of the molecular determinants of high
pathogenicity of the 1918 IAV. NS1 of the 1918 IAV (1918 NS1) contains a proline-rich motif (PRM) that mediates
binding with host CrkII with high affinity and selectivity. The 1918 NS1:CrkII interaction plays critical roles in the
suppression of host anti-viral immune responses and the enhancement of viral replication. Moreover, NS1s of
many avian/swine IAVs contain the CrkII-binding PRM. Given the zoonotic potential of IAVs, there is a critical
need to determine the molecular mechanisms by which the interaction of 1918 NS1 and cellular CrkII is regulated.
The long-term goal of our research program is to elucidate the molecular mechanisms underlying virus-host
protein interactions. Our objectives in this proposal are to determine the structural mechanisms of the 1918
NS1:CrkII interaction, and to determine the molecular and cellular mechanisms whereby the 1918 NS1:CrkII
complex induces PI3K activation, resulting in enhanced viral replication. Our central hypothesis is that the 1918
NS1:CrkII complex is structurally dynamic, which is functionally important for the interaction with the p85
regulatory subunit of PI3K. To test this hypothesis, we will determine the structure of the 1918 NS1:CrkII complex
and elucidate how the complex interacts with p85 to activate the PI3K signaling pathway. Our rationale for these
studies is that the mechanistic understanding of the interactions of 1918 NS1 with CrkII and p85 would help
identify previously undiscovered target sites to develop for potential inhibitors against the 1918 NS1. Through a
synergistic approach combining small-angle X-ray scattering, NMR spectroscopy, molecular dynamics
simulation, and cell-based assays, we will pursue the following specific aims. Aim 1. To determine the structural
mechanism of the 1918 NS1:CrkII interaction using a battery of biophysical experiments. Hijacking and relocation
of CrkII into the nucleus is a distinctive feature of the 1918 pandemic IAV NS1. To understand this process, we
will reveal structural and energetic mechanisms by which the affinity and lifetime (1/koff) of the 1918 NS1:CrkII
complex are modulated. Aim 2. To determine the molecular mechanism underlying NS1-induced PI3K activation.
The 1918 NS1:CrkII interaction markedly enhances NS1-induced PI3K activation; however, its molecular
mechanism is unknown. We will seek to comprehensively determine the molecular mechanisms by which the
1918 NS1:CrkII complex interacts with the p85 subunit of PI3K, reveal its functional role in PI3K activation, and
identify hotspot NS1 residues that interact with both CrkII and p85. This study is expected to have a positive
impact on the development of anti-viral agents targeting NS1-host protein interactions.
1918年的甲型流感病毒(IAV),也被称为西班牙流感,引起了人类最严重的流感大流行
历史非结构蛋白1(NS 1)是一种多功能的毒力因子,与抗-
病毒免疫应答,因此已被鉴定为高免疫应答的分子决定因素之一。
1918年IAV的致病性1918年IAV的NS 1(1918 NS 1)含有一个富含脯氨酸的基序(PRM),其介导
以高亲和力和选择性与宿主CrkII结合。1918年NS 1:CrkII相互作用在
抑制宿主抗病毒免疫应答和增强病毒复制。此外,
许多禽类/猪IAV含有CrkII结合PRM。考虑到IAV的人畜共患病潜力,
需要确定1918 NS 1和细胞CrkII相互作用的分子机制。
我们研究计划的长期目标是阐明病毒宿主的分子机制
蛋白质相互作用我们的目标是确定1918年的结构机制,
NS 1:CrkII相互作用,并确定1918 NS 1:CrkII相互作用的分子和细胞机制。
复合物诱导PI 3 K活化,导致增强的病毒复制。我们的核心假设是,1918年
NS 1:CrkII复合物是结构动态的,其在与p85蛋白相互作用中具有重要的功能。
PI 3 K调节亚基。为了验证这一假设,我们将确定1918年NS 1:CrkII复合物的结构。
并阐明该复合物如何与p85 β相互作用以激活PI 3 K信号通路。我们的理由
研究表明,1918 NS 1与CrkII和p85 β相互作用的机制理解将有助于
确定以前未发现的靶位点,以开发针对1918 NS 1的潜在抑制剂。通过
结合小角X射线散射、NMR光谱、分子动力学的协同方法
模拟和基于细胞的测定,我们将追求以下具体目标。目标1.为了确定结构
1918年NS 1:CrkII相互作用的机制,使用生物物理实验电池。劫持和迁移
CrkII进入细胞核是1918年大流行IAV NS 1的显著特征。为了理解这个过程,我们
将揭示1918年NS 1:CrkII的亲和力和寿命(1/koff)的结构和能量机制
复合物被调制。目标二。确定NS 1诱导PI 3 K活化的分子机制。
1918 NS 1:CrkII相互作用显著增强NS 1诱导的PI 3 K活化;然而,其分子生物学效应不显著。
机制不明。我们将寻求全面确定的分子机制,
1918 NS 1:CrkII复合物与PI 3 K的p85 β亚基相互作用,揭示了其在PI 3 K活化中的功能作用,
鉴定与CrkII和p85 β相互作用热点NS 1残基。这项研究预计将有一个积极的
对靶向NS 1-宿主蛋白相互作用的抗病毒药物的发展的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jae Hyun Cho其他文献
Jae Hyun Cho的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jae Hyun Cho', 18)}}的其他基金
Structure and functional dynamics of virus-host protein interactions
病毒-宿主蛋白相互作用的结构和功能动力学
- 批准号:
10473691 - 财政年份:2018
- 资助金额:
$ 31.36万 - 项目类别:
Structure and functional dynamics of virus-host protein interactions
病毒-宿主蛋白相互作用的结构和功能动力学
- 批准号:
9789044 - 财政年份:2018
- 资助金额:
$ 31.36万 - 项目类别:
Structure and functional dynamics of virus-host protein interactions
病毒-宿主蛋白相互作用的结构和功能动力学
- 批准号:
10581354 - 财政年份:2018
- 资助金额:
$ 31.36万 - 项目类别:
相似海外基金
Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
- 批准号:
23K18186 - 财政年份:2023
- 资助金额:
$ 31.36万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
- 批准号:
10560883 - 财政年份:2023
- 资助金额:
$ 31.36万 - 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10730692 - 财政年份:2021
- 资助金额:
$ 31.36万 - 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
- 批准号:
21K06459 - 财政年份:2021
- 资助金额:
$ 31.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10189880 - 财政年份:2021
- 资助金额:
$ 31.36万 - 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
- 批准号:
2404261 - 财政年份:2020
- 资助金额:
$ 31.36万 - 项目类别:
Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10222540 - 财政年份:2020
- 资助金额:
$ 31.36万 - 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10669717 - 财政年份:2020
- 资助金额:
$ 31.36万 - 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
- 批准号:
20K10713 - 财政年份:2020
- 资助金额:
$ 31.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10174522 - 财政年份:2020
- 资助金额:
$ 31.36万 - 项目类别:














{{item.name}}会员




